MYBL1 and adrenal cortex carcinoma: The identification of recurring t(6;9) and t(8;9) chromosomal translocations resulting in MYB-NFIB and MYBL1-NFIB fusion oncogenes and the unravel of the role of super-enhancer translocations in the oncogene activation, dramatically extend our understanding of the role of the MYB transcription factors in the pathogenesis of ACC.